Results 1 to 10 of about 298,377 (234)

Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis

open access: yesHealth Technology Assessment, 2023
Background Severe acute respiratory syndrome coronavirus 2 is the virus that causes coronavirus disease 2019. Over six million deaths worldwide have been associated with coronavirus disease 2019.
Metry Andrew   +7 more
doaj   +1 more source

Cost-utility analysis of thrombolytic therapy [PDF]

open access: yesEuropean Heart Journal, 1991
An analysis of the cost-effectiveness of thrombolytic therapy was performed, based on 3- to 5-year follow-up data, from 533 patients randomized to receive conventional therapy or intracoronary streptokinase. At the 3-year follow-up, mortality was 22% in the former group and 14% after thrombolysis.
M L, Simoons, J, Vos, L L, Martens
openaire   +2 more sources

Economic evaluation of using pesticides to control cutaneous leishmaniasis in Isfahan

open access: yesJournal of Research in Pharmacy Practice, 2018
Objective: Pesticides have been used as the main part of the national cutaneous leishmaniasis control program for serveral years in Iran. However, the cost-effectiveness of this strategy has not been yet analyzed.
Ehsanallah Jafari   +3 more
doaj   +1 more source

Cost‐utility analysis of radiofrequency ablation versus optimal medical therapy in managing supraventricular tachycardia among Filipinos

open access: yesJournal of Arrhythmia, 2023
Background Radiofrequency ablation (RFA) is the standard of care in the management of supraventricular tachycardia (SVT). Its cost‐effectiveness in an emerging Asian country has not been studied.
Giselle G. Gervacio   +6 more
doaj   +1 more source

Cost-utility analysis of ceftolozane/tazobactam vs meropenem in patients with hospital-acquired pneumonia (HABP) or ventilator-associated pneumonia (VABP)

open access: yesGlobal & Regional Health Technology Assessment, 2022
Obiettivo: Questo studio ha lo scopo di valutare il rapporto costo-efficacia di ceftolozano/tazobactam rispetto a meropenem per il trattamento di pazienti con polmonite acquisita in ospedale (HABP) o polmonite associata a ventilazione meccanica (VABP ...
Francesco Saverio Mennini   +5 more
doaj   +1 more source

Cost–utility analysis of bariatric surgery

open access: yesBritish Journal of Surgery, 2018
AbstractBackgroundThe objective of the study was to evaluate the cost–utility of bariatric surgery in England.MethodsA state-transition Markov model was developed to compare the costs and outcomes of two treatment approaches for patients with morbid obesity: bariatric surgery, including gastric bypass, sleeve gastrectomy and adjustable gastric banding;
O Borisenko, V Lukyanov, A R Ahmed
openaire   +4 more sources

The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a randomized controlled clinical Trial (ESCoRT study)

open access: yesBMC Medical Informatics and Decision Making, 2021
Background Tumor necrosis factor α inhibitors (TNFi) is effective for rheumatoid arthritis (RA) patients who fail to conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs).
Juan Zhao   +6 more
doaj   +1 more source

A Systematic Review of Economic Evaluations of Active Tuberculosis Treatments

open access: yesFrontiers in Pharmacology, 2021
Background: The disease burden of active tuberculosis (TB) is considerable, but systematic reviews of economic evaluations of active TB treatments are scarce.Methods: PubMed, EMBASE, and the Cochrane Library databases were used to search for articles on ...
Joo-Young Byun   +3 more
doaj   +1 more source

METHODS OF ANALYSIS OF THE EFFECTIVENESS OF PUBLIC SECTOR PROJECTS: FEATURES AND CONSTRAINTS [PDF]

open access: yesBaltic Journal of Economic Studies, 2018
The purpose of the paper is to consider the main provisions of methods of analysis of the effectiveness of public sector projects. A number of issues remain controversial in the methodology of analysing costs and benefits.
Volodymyr Lipkan   +2 more
doaj   +1 more source

Cost-utility analysis of nonalcoholic steatohepatitis screening [PDF]

open access: yesEuropean Radiology, 2015
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in Western countries. No studies have examined the cost-effectiveness of screening its advanced form, nonalcoholic steatohepatitis (NASH).We performed a cost-utility analysis of annual noninvasive screening strategies using third-party payer perspective in a general population in
Eric, Zhang   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy